Wyeth Must Conduct Additional Safety Test

The Food and Drug Administration requested that Wyeth (WYE) conduct an additional safety test before considering the company's antidepressant Pristiq for approval. Shares of the pharmaceutical plunged $5.70 to close at $50.30.